481 related articles for article (PubMed ID: 23023723)
1. Osteoporosis and adynamic bone in chronic kidney disease.
Cannata-Andía JB; Rodriguez García M; Gómez Alonso C
J Nephrol; 2013; 26(1):73-80. PubMed ID: 23023723
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
Amerling R; Harbord NB; Pullman J; Feinfeld DA
Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
[TBL] [Abstract][Full Text] [Related]
3. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
[TBL] [Abstract][Full Text] [Related]
6. Adynamic bone disease: from bone to vessels in chronic kidney disease.
Bover J; Ureña P; Brandenburg V; Goldsmith D; Ruiz C; DaSilva I; Bosch RJ
Semin Nephrol; 2014 Nov; 34(6):626-40. PubMed ID: 25498381
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of fracture risk in chronic kidney disease.
Torres PAU; Cohen-Solal M
J Nephrol; 2017 Oct; 30(5):653-661. PubMed ID: 28386879
[TBL] [Abstract][Full Text] [Related]
8. Bisphophonates in CKD patients with low bone mineral density.
Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
[TBL] [Abstract][Full Text] [Related]
9. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Hsu CY; Chen LR; Chen KH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis management in patient with renal function impairment.
Lima GA; Paranhos Neto Fde P; Pereira GR; Gomes CP; Farias ML
Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):530-9. PubMed ID: 25166044
[TBL] [Abstract][Full Text] [Related]
12. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
13. When, how, and why a bone biopsy should be performed in patients with chronic kidney disease.
Torres PU; Bover J; Mazzaferro S; de Vernejoul MC; Cohen-Solal M
Semin Nephrol; 2014 Nov; 34(6):612-25. PubMed ID: 25498380
[TBL] [Abstract][Full Text] [Related]
14. Changes in Bone Histomorphometry after Kidney Transplantation.
Keronen S; Martola L; Finne P; Burton IS; Kröger H; Honkanen E
Clin J Am Soc Nephrol; 2019 Jun; 14(6):894-903. PubMed ID: 31088851
[TBL] [Abstract][Full Text] [Related]
15. Management of osteoporosis in patients with chronic kidney disease.
Abdalbary M; Sobh M; Elnagar S; Elhadedy MA; Elshabrawy N; Abdelsalam M; Asadipooya K; Sabry A; Halawa A; El-Husseini A
Osteoporos Int; 2022 Nov; 33(11):2259-2274. PubMed ID: 35748896
[TBL] [Abstract][Full Text] [Related]
16. Bone disease in CKD: a focus on osteoporosis diagnosis and management.
Miller PD
Am J Kidney Dis; 2014 Aug; 64(2):290-304. PubMed ID: 24726630
[TBL] [Abstract][Full Text] [Related]
17. Bone alkaline phosphatase in CKD-mineral bone disorder.
Sardiwal S; Magnusson P; Goldsmith DJ; Lamb EJ
Am J Kidney Dis; 2013 Oct; 62(4):810-22. PubMed ID: 23623575
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review.
Ginsberg C; Ix JH
Am J Kidney Dis; 2022 Mar; 79(3):427-436. PubMed ID: 34419519
[TBL] [Abstract][Full Text] [Related]
19. Fracture risk and treatment in chronic kidney disease.
Connelly K; Collister D; Tangri N
Curr Opin Nephrol Hypertens; 2018 May; 27(3):221-225. PubMed ID: 29547405
[TBL] [Abstract][Full Text] [Related]
20. How to predict and treat increased fracture risk in chronic kidney disease.
West SL; Patel P; Jamal SA
J Intern Med; 2015 Jul; 278(1):19-28. PubMed ID: 25758353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
